Articles

Find an Article

Filter articles

Showing 51 to 60 of 718 results

Event preview: Life Sciences IP Due Diligence summit

US22-10-2019

The Annual Summit on Life Sciences IP Due Diligence to be held on November 14 and 15 in Boston, MA, is a one-of-a-kind, interactive forum where diligence experts discuss best practices and strategies for executing a proper IP due diligence analysis for incumbent portfolios and those of potential targets.

Medicinal cannabis: what next for Brazil?

Brazil21-10-2019Ludmila Kawakami and Ana Paula Couto

Tensions between public use, drug laws and regulators make IP around Cannabis a complex situation, explains Ludmila Kawakami and Ana Paula D. C. Couto of Di Blasi, Parente & Associados.

Conference preview: LSX World Congress USA

04-10-2019Paul Gilbertson

LSX World Congress USA brings life sciences investment and partnering to Boston.

CRISPR: A licence to heal

US01-10-2019Rory O'Neill

As all sides prepare for a milestone case in the battle over rights to CRISPR/Cas9, LSIPR’s Rory O’Neill finds the CEO of ERS Genomics in a positive mood.

Brexit: The waiting game

UK01-10-2019Saman Javed

As lawyers and industry prepare for a possible no-deal Brexit, the uncertainty surrounding its impact is palpable, as LSIPR’s Saman Javed discovers.

M&A: Year of the megadeal

UK, US30-09-2019

LSIPR’s Sarah Morgan investigates the current state of play of M&A in the sector and predicts the next year of activity.

IP portfolios: the five biggest headaches for in-house counsel

International30-09-2019

In-house counsel face daily challenges when managing and maintaining their IP portfolios. LSIPR asked two in-house counsel for the biggest challenges they face when managing and maintaining their IP portfolios. Here are the five things we learned.

Pharma: A Mexican tradeoff

Mexico30-09-2019Margarita Guerrero Gonzalez

While providing benefits to Mexico’s biologics system, the USMCA may also increase costs for citizens, argues Margarita Guerrero Gonzalez of Uhthoff, Gomez Vega & Uhthoff.

Genetic research: DNA payday

International30-09-2019Rory O'Neill

A tie-up between four leading pharmaceutical companies, the UK government and a health charity has created the world’s largest genetic research project. LSIPR’s Rory O’Neill looks at a new frontier for life sciences.

Secondary patents: Moscow mewl

Russia30-09-2019Maxim Sobolev

An intervention by Russia’s IP ombudsman seeks to solve the validity issue over secondary patents, but is it needed, asks Maxim Sobolev of Rouse.

Showing 51 to 60 of 718 results

LSIPR